Drawing for BIONANO

USPTO serial 97672600

BIONANO

Reviewed by CopyMark Law Group

Reg. 8005396Status 700Registered
Filing date
Status date
Registration date
Oct 28, 2025
Examiner
STEINPFAD, SARAH E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BIONANO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ian W. Gillies

Ian W. Gillies KNOBBE, MARTENS, OLSON & BEAR, LLP2040 MAIN STREET, 14TH FLOORIRVINE, CA 92614United States

Goods and services

ClassDescriptionStatusFirst use
001Reagents for use in preparing molecules for genomic research and analysis; a kit for extracting and labeling biopolymers for research purposes, containing enzymes, color reagents, buffers, and other reagents; Polynucleotide isolation and purification kit consisting of enzymes, color reagents, buffers, and other reagents used for scientific or medical research purposes; kits for extracting and labeling polynucleotide molecules for research purposes, containing enzymes, color reagents, buffers, and other reagents; reagents for use in preparing polynucleotide molecules for genomic research; diagnostic kits containing enzymes, color reagents, buffers, and other reagents for extracting and labeling polynucleotide moleculesACTIVEJan 23, 2023
009An imaging system, namely, an imaging apparatus and downloadable and recorded software, for the analysis of biopolymer samples in scientific or medical research; downloadable and recorded software used in the analysis of biopolymer samples for medical diagnostic purposes; downloadable and recorded software used in the analysis of biopolymer samples for scientific or medical research; an imaging apparatus for use in the analysis of biopolymer samples in scientific or medical research; Nanofluidic devices, namely, solid state substrates in the nature of plates, chips and wafers, and downloadable and recorded software, both of the foregoing for genomic imaging and analysis; An imaging apparatus and downloadable and recorded software for genomic analysis in scientific or medical research; an imaging system, namely, an imaging apparatus and downloadable and recorded software sold as a unit, for genomic analysis in scientific or medical research; downloadable and recorded software for genomic analysis used for medical diagnostic purposes, and in scientific, clinical, and medical research; downloadable and recorded genomic data analysis software; downloadable and recorded software for interpreting and analyzing data generated by an imaging apparatus for the purpose of studying biopolymer samples; Solid state substrates, namely, plates, chips, and wafers for use in scientific or medical research, having a pattern of channels for confining and linearizing biopolymer samples; disposable substrates, namely, plates, chips, and wafers for use in scientific or medical research, having a pattern of channels to facilitate genomic imaging and analysis; Solid state substrates, namely, plates, chips and wafers having a plurality of fluid passageways for confining and linearizing macromolecules including biopolymer molecules for scientific or medical research; nanochannel wafers, for scientific or medical research, used in instruments for genomic analysis; downloadable and recorded software in the field of genomic bioinformatics for processing, storing, analyzing, presenting, interpreting, and sharing genomic dataACTIVEJan 23, 2023
042product research and development and consulting services for others in the fields of biopolymer imaging and analysis; genomic mapping, genomic imaging, and genomic analysis services for scientific research purposes; medical, pharmaceutical, biotechnology, and scientific research and consulting services in the field of genetics, namely, analysis of relationships between genetic variants and neurodevelopmental disorders, genetic research, bio-marker discovery research, and pheno-typing for identifying, testing and developing diagnostics and treatments for human diseases and human disorders; software as a service (SAAS) services and platform as a service (PAAS) featuring software and computer software platforms featuring software in the field of genomics for processing, storing, analyzing, presenting, interpreting, and sharing genomic data; product research and development and consulting services for others in the fields of genomic bioinformatics and data analysis; genomic data analysis services for scientific, clinical, and medical research purposesACTIVEJan 23, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 28, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 28, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 3, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 3, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 1, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 30, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 2, 2025IUAFUSE AMENDMENT FILED—
May 2, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 28, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 28, 2024EX1GSOU EXTENSION 1 GRANTED—
Oct 28, 2024EXT1SOU EXTENSION 1 FILED—
Oct 28, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 7, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 12, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 12, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 21, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 21, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 7, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 2, 2024DOCKASSIGNED TO EXAMINER—
Dec 27, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 26, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 26, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 22, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Sep 22, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jun 28, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2023DOCKASSIGNED TO EXAMINER—
Dec 1, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 14, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance